These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27072728)

  • 1. Paraneoplastic Systemic Sclerosis: Focus on Anti-RNA Polymerase III Antibodies.
    Heymann WR
    Skinmed; 2016; 14(1):39-40. PubMed ID: 27072728
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of mucosa-associated lymphoid tissue lymphoma and systemic sclerosis showing positive for anticentromere antibody and anti-RNA polymerase III antibody: A case report and published work review.
    Fukumoto T; Matsuoka H; Kitani M; Sugiyama M; Fukunaga A; Nishigori C
    J Dermatol; 2018 Dec; 45(12):e337-e339. PubMed ID: 29797523
    [No Abstract]   [Full Text] [Related]  

  • 3. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
    Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P
    Front Immunol; 2018; 9():3112. PubMed ID: 30687318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
    Benyamine A; Bertin D; Heim X; Granel B; Bardin N
    Eur J Intern Med; 2017 Oct; 44():e42-e44. PubMed ID: 28781194
    [No Abstract]   [Full Text] [Related]  

  • 5. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
    Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
    Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.
    Shah AA; Rosen A
    Curr Opin Rheumatol; 2011 Nov; 23(6):530-5. PubMed ID: 21825998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-RNA Polymerase II Antibodies in a U.S. Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et al.
    Patel V; Assassi S; Mayes MD; Feghali-Bostwick CA
    Arthritis Rheumatol; 2015 Sep; 67(9):2547-8. PubMed ID: 25988706
    [No Abstract]   [Full Text] [Related]  

  • 10. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
    Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
    Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
    Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
    J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies.
    Rosato E; Navarini L; Gigante A; Cianci R; Margiotta D; Barbano B; Afeltra A
    Rheumatology (Oxford); 2017 Jun; 56(6):1039-1041. PubMed ID: 28340199
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
    Ceribelli A; Cavazzana I; Airò P; Franceschini F
    J Rheumatol; 2010 Jul; 37(7):1544. PubMed ID: 20595295
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.
    Watson KD; Makol A
    Rheumatology (Oxford); 2017 Nov; 56(11):1856. PubMed ID: 29088451
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
    Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
    Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
    Hesselstrand R; Scheja A; Wuttge DM
    Scand J Rheumatol; 2012 Feb; 41(1):39-43. PubMed ID: 22044051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.
    Deguchi A; Yamaoka T; Komurasaki Y; Hayashi M; Kiyohara E; Murota H; Katayama I
    Clin Exp Dermatol; 2017 Mar; 42(2):200-201. PubMed ID: 27739106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.